Why the study?
Does the combination of TACE and EBRT improve survival and safety in patients with HCC and tumor thrombus in the IVC and RA?
Population
11 cases of hepatocellular carcinoma with a tumor thrombus in the inferior vena cava and right atrium
Design
Case_series
Follow-up
up to 97 months
Authors
Loading...
Hypothesis-generating for TACE plus EBRT in HCC with IVC/RA thrombus; leaves open need for prospective validation.
Does the combination of TACE and EBRT improve survival and safety in patients with HCC and tumor thrombus in the IVC and RA?
The combination of TACE and EBRT appears safe and may improve survival in patients with HCC complicated by tumor thrombus extending into the IVC and right atrium.
Duan et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: